IKT INHIBIKASE THERAPEUTICS INC Investments/Divestments 8-K Filing 2023 - Securities Purchase Agreements for Registered Direct Offering and Private Placement Inhibikase Therapeutics, Inc. entered into securities purchase agreements for a registered direct offering and concurrent private placement, expecting to receive gross proceeds of approximately $10 million.Get access to all SEC 8-K filings of the INHIBIKASE THERAPEUTICS INC